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We report a 37-year-old woman with an out-of-hospital cardiac arrest caused by ventricular ﬁbrillation due to digenic inheritance
of long QT syndrome type 2 (KCNH2 gene) and type 6 (KCNE2 gene). During hospitalization, prolonged QTc intervals and
frequent episodes of ventricular tachyarrhythmias manifested. Genetic testing identiﬁed a mutation of the KCNH2 gene and an
unclassiﬁed variant, most likely pathogenic, of the KCNE2 gene. ,is digenic inheritance is extremely rare.
1. Introduction
In the past decennia, our knowledge of the genetic etiology of
cardiac arrhythmias has enormously increased. Cardiac
tachyarrhythmias may be caused by several hereditary dis-
eases including primary electrical disorders, such as long QT
syndrome (LQTS) [1]. ,e LQTS is characterized by a pro-
longation of cardiac repolarization (QTc >450ms in men and>460ms in women), leading to ventricular tachyarrhythmias
such as torsade des pointes (TdP). Consequently, aﬀected
patients have an increased risk of syncope and sudden cardiac
death (SCD).,e genes that are associated with LQTS include
KCNQ1 (LQT1), KCNH2 (LQT2), SCNA5 (LQT3), KCNE1
(LQT5), andKCNE2 (LQT6) in addition to a few less frequent
subtypes [2]. ,e most frequent variants of LQTS involve the
KCNQ1, theKCNH2, and the SCN5A genes which account for
approximately 90% of genotype-positive patients. Less fre-
quent variants of LQTS involve the KCNE1 and KCNE2 genes
[3, 4].,is case report is to our knowledge the ﬁrst to describe
the digenic inheritance of long QTsyndrome type 2 (KCNH2
gene) and type 6 (KCNE2 gene).
2. Case Report
A 37-year-old Iraqi woman, living in the Netherlands, with
no cardiac history, was brought to the emergency
department with an out-of-hospital cardiac arrest (OHCA)
due to ventricular ﬁbrillation (VF). ,at evening, she had
suddenly collapsed without any warnings. After two to three
minutes, the police started with basic life support, and the
paramedics arrived after ten minutes. On arrival, VF was
documented, and after three direct current shocks, sinus
rhythm was restored.
She was a nonsmoker, and there was no history of drug
abuse. Current medications included diclofenac, mebe-
verine, and vitamin supplements. Her medical history
consisted of a gastric banding operation one year ago, and
prior to the event, she had only experienced some dizziness
at times. ,e postoperative course of the gastric banding
operation was uncomplicated. Her mother and four sib-
lings lived in diﬀerent countries around the world, so there
was limited information about her family history. Her
father passed away at the age of 55 due to complications of
diabetes mellitus. ,e only thing that is known is that her
family history was negative for SCD or cardiac disorders.
Both of her sons had been diagnosed with autism but were
in good physical health. ,e 12-lead electrocardiogram at
presentation showed sinus rhythm with a frequency of 103
beats per minute and frequent premature ventricular
complexes in bigeminy pattern with a QTc interval of
419ms (Figure 1). A computed tomography (CT) scan of
the thorax and cerebrum showed no evident abnormalities.
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After therapeutic hypothermia of 24 hours, she regained
consciousness with reasonable neurological recovery
without apparent sequela. Furthermore, a transthoracic
echocardiogram demonstrated a good left and right ven-
tricular function and no valvular abnormalities.
Days after detubation, episodes of frequent premature
beats, nonsustained ventricular tachycardias, and prolonged
QTc intervals manifested, and treatment with propranolol
was started. Furthermore, frequent episodes of torsade des
pointes were observed (Figure 2). Cordarone was given,
which resulted in progression of the torsade des pointes into
VF requiring electrical cardioversion. Cordarone treatment
was discontinued. Laboratory tests showed a mild hypo-
natremia of 134mmol/l, a hypokalemia of 3.1mmol/l, and a
normal calcium level of 2.38mmol/l. However, after elec-
trolyte corrections, ventricular tachyarrhythmias persisted.
During hospitalization, the QTc interval varied between
normal (<460ms) and severely prolonged (552ms) (Fig-
ure 3). Due to bradycardias, treatment with propranolol was
discontinued. Eventually, sinus rhythm was achieved with
ﬂecainide. Coronary angiography showed no coronary ar-
tery stenosis, and cardiac magnetic resonance imaging also
revealed no abnormalities.
A dual-chamber implantable cardioverter-deﬁbrillator
was implanted for secondary prevention. Subsequently,
genetic testing for the LQT1, LQT2, LQT3, LQT5, and LQT6
genes identiﬁed a heterozygous c.3092_3096dup (p.Arg1033
ValfsX26) mutation of the KCNH2 gene (LQT2) and a
heterozygous c.170T>C (p.Ile57,r) unclassiﬁed variant
(UV) of the KCNE2 gene (LQT6). ,e UV (missense mu-
tation) of the KCNE2 gene is likely a pathogenic mutation,
what results in the digenic inheritance of LQT2 and LQT6.
Genetic screening revealed that both sons are not carrying
the familial KCNH2mutation. ,ey have not been tested for
the UV of the KCNE2 gene.
3. Discussion
,is case report describes a patient with an OHCA due to VF
with the coexistence of a mutation in the KCNH2 gene
(LQT2) and an UV of the KCNE2 gene (LQT6). An UV is a
genetic sequence whose association with, in this case, LQTS
is uncertain. In uncertain negative results, these UVs have
not been found in aﬀected counselees at high risk of LQTS.
,is is presumably the reason why both sons have not been
tested for the UV of the KCNE2 gene. Prior studies reported
that this KCNE2 UV is most likely a pathogenic mutation
because it was not present in 1300 healthy controls, it causes
spontaneous and drug-induced prolongation of cardiac
repolarization, and it has a loss-of-function eﬀect on the Ikr
current [3, 5–7].,e KCNH2 and KCNE2 genes both encode
the Ikr channel, but for diﬀerent subunits. ,e KCNH2 gene
encodes the HERG subunits and theKCNE2 gene theMiRP1
subunit. It was found that theMiRP1mutants and theHERG
mutants both form channels that conduct diminished po-
tassium currents [5–8]. ,ese data indicate that these two
mutations combined might have an aggravating eﬀect on
loss of function of the Ikr channel.
Patients with digenic mutations are relatively common.
Studies showed that in 4.6% to approximately 10.0% of the
LQTS patients, two mutations were found [4, 9, 10]. To our
knowledge, the coexistence of mutations in the LQT2 and
LQT6 has never been described before. Mutations in the
KCNH2 gene are common and often involved in the digenic
inheritance of LQTS. However, LQTS is in <1% caused by
mutations in the KCNE2 gene: Tester et al. found only one
KCNE2mutation in 541 unrelated patients [4].,e coexistence
of LQT2 and LQT6 in one individual is thus extremely rare.
Patients with two or more mutations were more likely to
have a severe clinical manifestation of LQTS. ,e QTc in-
tervals were longer, and patients had more often cardiac
Figure 1: ,e 12-lead electrocardiogram with sinus rhythm (103 beats per minute) and frequent premature ventricular complexes in
bigeminy pattern.
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arrhythmias and symptoms such as syncope and cardiac
arrest [9, 10]. Furthermore, the onset of cardiac events in
digenic inheritance is at a signiﬁcantly younger age
(10± 8 years vs 18± 16 years) [11]. However, our patient was
37 years old when she experienced her ﬁrst cardiac event.
,e late presentation could be related to the fact that this
KCNE2 UV in an isolated setting has not previously been
associated with severe clinical manifestations, only a pro-
longed QTduration [12, 13]. A severe phenotype of this UV
has only been described in combination with LQT3 in
patients presenting with neonatal seizures and ventricular
tachycardia [13]. Perhaps, exacerbation of symptoms for this
KCNE2 UV is solely triggered in susceptible situations, for
example, use of drugs that inhibit cardiac potassium
channels [6]. In digenic inheritance, the variant may
therefore have a subordinate role and cause no aggravating
phenotypic expression over the single LQTS mutation. ,e
ﬁndings of Westenskow et al. and Schwartz et al. are based
on other combinations of digenic mutations, and the clinical
expression of the combination of LQT2 and LQT6 is not yet
described and may diﬀer. In addition, the disease course of
this patient can also be attributed to the variable penetrance
of LQTS. She had, however, experienced dizziness prior to
the event, which may indicate she had unconsciously suf-
fered from TdP.
Nevertheless, it is possible that the combination of
LQT2/LQT6 occurs more frequently than reported. Because
most genotype-positive patients have a mutation in KCNQ1,
KCNH2, or SCNA5 genes, it was recommended only to test
these genes [14, 15]. However, in our case, mutations in
other LQT genes could have been missed. Consequently, a
potential (second) mutation will be left undiagnosed in the
patient and family members. Because of the relatively high
prevalence and predictive value of digenic mutations,
screening of all the LQTS genes should be considered in
every patient. As a result, there will be an increased risk of
ﬁnding UVs which may give distress because of its un-
certainty. However, if a patient carries a heterozygous
mutation in two diﬀerent genes, the risk that a child inherits
both mutations is 25%, which implicates a more severe
phenotype requiring close follow-up. By not screening all the
LQTS genes, this would be missed. Napolitano et al. showed
that, contrary to common perception, at least 88% of the
LQTS patients have inherited the disease [14]. ,is states the
importance of genetic screening of family members of LQTS
patients as well. Furthermore, genetic screening will provide
more information about the clinical presentation and in-
cidence of the coexistence of LQT2 and LQT6.
4. Conclusion
,e coexistence of long QTsyndrome type 2 (KCNH2 gene)
and type 6 (KCNE2 gene) is extremely rare. Screening of all
the long QT syndrome genes should be considered in every
patient and family member to not leave a potential (second)
mutation undiagnosed.
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